Regeneron Pharmaceuticals (REGN) Property, Plant & Equipment (Net) Growth (5y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.05% |
| Dec 31, 2025 | 9.71% |
| Sep 30, 2025 | 9.77% |
| Jun 30, 2025 | 9.81% |
| Mar 31, 2025 | 9.78% |
| Dec 31, 2024 | 9.74% |
| Sep 30, 2024 | 9.88% |
| Jun 30, 2024 | 9.98% |
| Mar 31, 2024 | 10.09% |
| Dec 31, 2023 | 9.99% |
| Sep 30, 2023 | 9.68% |
| Jun 30, 2023 | 9.77% |
| Mar 31, 2023 | 10.14% |
| Dec 31, 2022 | 9.79% |
| Sep 30, 2022 | 10.25% |
| Jun 30, 2022 | 9.97% |
| Mar 31, 2022 | 9.33% |
| Dec 31, 2021 | 10.82% |
| Sep 30, 2021 | 12.65% |
| Jun 30, 2021 | 13.63% |
| Mar 31, 2021 | 14.38% |
| Dec 31, 2020 | 15.11% |
| Sep 30, 2020 | 16.30% |
| Jun 30, 2020 | 17.98% |
| Mar 31, 2020 | 21.53% |
| Dec 31, 2019 | 24.29% |
| Sep 30, 2019 | 27.61% |
| Jun 30, 2019 | 30.49% |
| Mar 31, 2019 | 34.17% |
| Dec 31, 2018 | 37.35% |
| Sep 30, 2018 | 40.94% |
| Jun 30, 2018 | 42.45% |
| Mar 31, 2018 | 43.59% |
| Dec 31, 2017 | 44.07% |
| Sep 30, 2017 | 43.57% |
| Jun 30, 2017 | 43.45% |
| Mar 31, 2017 | 43.83% |
| Dec 31, 2016 | 41.45% |
| Sep 30, 2016 | 38.76% |
| Jun 30, 2016 | 37.41% |
| Mar 31, 2016 | 36.06% |
| Dec 31, 2015 | 35.62% |
| Sep 30, 2015 | 35.88% |
| Jun 30, 2015 | 35.31% |
| Dec 31, 2014 | 30.27% |